Vijaya Diagnostic Centre Limited Stock price

Equities

VIJAYA

INE043W01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. 08:02:02 2024-03-28 am EDT 5-day change 1st Jan Change
636.6 INR +0.46% Intraday chart for Vijaya Diagnostic Centre Limited +1.39% -5.79%
Sales 2024 * 5.43B 65.18M Sales 2025 * 6.69B 80.23M Capitalization 64.86B 778M
Net income 2024 * 1.19B 14.24M Net income 2025 * 1.5B 18.04M EV / Sales 2024 * 11.6 x
Net cash position 2024 * 1.91B 22.88M Net cash position 2025 * 3.04B 36.45M EV / Sales 2025 * 9.24 x
P/E ratio 2024 *
54.5 x
P/E ratio 2025 *
43 x
Employees 1,996
Yield 2024 *
0.27%
Yield 2025 *
0.28%
Free-Float 45.1%
More Fundamentals * Assessed data
Dynamic Chart
Vijaya Diagnostic Centre's Consolidated Profit Jumps in Fiscal Q3 MT
Transcript : Vijaya Diagnostic Centre Limited, Q3 2024 Earnings Call, Feb 06, 2024
Vijaya Diagnostic Centre Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Vijaya Diagnostic Centre Completes Acquisition of PH Diagnostic MT
Transcript : P H Diagnostic Centre Private Limited, Vijaya Diagnostic Centre Limited - M&A Call
Vijaya Diagnostic Centre Limited completed the acquisition of P H Diagnostic Centre Private Limited. CI
Vijaya Diagnostic Centre to Acquire P H Diagnostic Centre for INR1.4 Billion MT
Vijaya Diagnostic Centre Limited entered into Share Purchase agreement to acquire P H Diagnostic Centre Private Limited for INR 1.3 billion. CI
Correction: Vijaya Diagnostic Centre's Consolidated Profit Jumps in Fiscal Q2; EPS, Revenue Top Estimates MT
Vijaya Diagnostic Centre Seeks M&A CI
Transcript : Vijaya Diagnostic Centre Limited, Q2 2024 Earnings Call, Nov 08, 2023
Vijaya Diagnostic Centre Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Vijaya Diagnostic Centre Limited Appoints Sura Suprita Reddy as Managing Director CI
Vijaya Diagnostic Centre Limited Appoints Sura Suprita Reddy as Chief Executive Officer CI
Transcript : Vijaya Diagnostic Centre Limited, Q1 2024 Earnings Call, Aug 10, 2023
More news

Latest transcript on Vijaya Diagnostic Centre Limited

1 day+0.50%
1 week+1.44%
Current month-1.18%
1 month-2.99%
3 months-2.72%
6 months+28.24%
Current year-5.74%
More quotes
1 week
622.25
Extreme 622.25
644.95
1 month
596.05
Extreme 596.05
653.35
Current year
596.05
Extreme 596.05
718.80
1 year
349.25
Extreme 349.25
718.80
3 years
295.00
Extreme 295
718.80
5 years
295.00
Extreme 295
718.80
10 years
295.00
Extreme 295
718.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 42 02-06-04
Director of Finance/CFO - 21-04-30
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 57 21-05-25
Founder 75 80-12-31
Director/Board Member 48 02-06-04
More insiders
Date Price Change Volume
24-03-28 636.6 +0.46% 82 137
24-03-27 633.7 -0.33% 56,212
24-03-26 635.8 +0.78% 85,903
24-03-22 630.9 +0.49% 77,292
24-03-21 627.8 +0.27% 79,824

Delayed Quote NSE India S.E., March 28, 2024 at 04:09 am EDT

More quotes
Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The Company operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The Company also offers a range of health and wellness packages to its customers as per their requirements. It operates approximately 121 diagnostic centers and 17 reference laboratories in 20 cities spread across India.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
633.7 INR
Average target price
690 INR
Spread / Average Target
+8.88%
Consensus
  1. Stock
  2. Equities
  3. Stock Vijaya Diagnostic Centre Limited - NSE India S.E.